Aspire Biopharma Holdings, Inc.
Develops sublingual drug delivery technologies for needle-free medications.
ASBP | US
Overview
Corporate Details
- ISIN(s):
- KYG7207P1110 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 23150 FASHION DRIVE, SUITE 232, 33928 ESTERO
- Website:
- https://www.powerupacq.com/
- Sector:
- Manufacturing
Description
Aspire Biopharma Holdings, Inc. is an early-stage biopharmaceutical company that develops and markets novel sublingual drug delivery technologies. The company's platform aims to enhance existing FDA-approved medications and nutraceuticals by creating needle-free, under-the-tongue formulations. Its development pipeline includes a sublingual version of aspirin, a needle-free semaglutide for diabetes and weight management, and a rapid-acting erectile dysfunction medication. Aspire is also exploring applications for its technology in areas such as anti-nausea, anti-psychotic, and seizure treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Aspire Biopharma Holdings, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Aspire Biopharma Holdings, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Aspire Biopharma Holdings, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
